Lv1
90 积分 2025-07-04 加入
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
2个月前
已完结
Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
2个月前
已完结
Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasis
2个月前
已完结
Comparative efficacy of osimertinib with and without radiation therapy in EGFR-mutated nonsmall cell lung cancer with brain metastases
2个月前
已完结
The influence of EGFR mutation status and PD-L1 expression in stage III unresectable non-small cell lung cancer treated with chemoradiation and consolidation durvalumab
1年前
已完结
Targeted Therapy as an Alternative to Whole-Brain Radiotherapy in EGFR-Mutant or ALK-Positive Non–Small-Cell Lung Cancer With Brain Metastases
1年前
已完结
Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data
1年前
已完结
Combined use of radiotherapy and tyrosine kinase inhibitors in the management of metastatic non-small cell lung cancer: a literature review
1年前
已完结
Toxicity in combination immune checkpoint inhibitor and radiation therapy: A systematic review and meta-analysis
1年前
已完结
Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies
1年前
已完结
皖公网安备34019202002308
